Research of subchronic oral toxicity after the injection of organotin compounds containing a fragment of 2,6-di-tert-butylphenol

Author:

Alkhusein-Kulyaginova M. S.1ORCID,Arkaniya I. I.1ORCID,Trepel V. V.1ORCID,Mogushkova S. A.1ORCID,Kirtanasova E. Y.1ORCID,Dodokhova M. A.1ORCID,Gulyan M. V.1ORCID,Shpakovsky D. B.2ORCID,Milaeva E. R.2ORCID,Kotieva I. M.1ORCID

Affiliation:

1. Rostov State Medical University

2. M.V. Lomonosov Moscow State University

Abstract

Objective: to assess the subchronic  toxicity of bis(3,5-di-tert-butyl-4-hydroxyphenyl)dimethyltin (Me-3) and (3,5-di-tert-butyl-4-hydroxyphenyl)triphenyltin (Me-5) with the identification  of external signs  of toxicity and changes  in the indicators of the functional state of the liver and kidneys of Wistar rats (females) with 14-fold daily intragastric injection to simulate a metronomic  chemotherapy  regimen. Materials and method: the study was conducted  on 24 Wistar rats (females) weighing 190-210 g. The tested compounds were administered  fourteen times daily intragastrically  at a total dose of 2000 mg/kg for Me-3, 954 mg/kg for Me-5. Results: for substances belonging to the class of organic tin derivatives: the features of the toxic process and indicators of the functional  state of detoxification  organs (liver and kidneys) with subchronic administration were revealed. The injection  in total doses amounting to a half-year dose with a fourteen-fold administration did not cause the death of animals and the development  of external signs of toxicity, changes in the functional state of the liver and kidneys were not noted. Conclusion: the analysis of the results of the study will allow us to develop optimal schemes for the injection of organotin compounds containing a fragment of 2,6-di-tert-butylphenol in the metronomic regimen.

Publisher

Rostov State Medical University

Subject

General Medicine

Reference17 articles.

1. Devi J, Boora A, Rani M, Arora T. Recent Advancements in Organotin(IV) Complexes as Potent Cytotoxic Agents. Anticancer Agents Med Chem. 2023;23(2):164-191. doi: 10.2174/1871520622666220520095549

2. Nikitin EA, Shpakovsky DB, Tyurin VY, Kazak AA, Gracheva YA, Vasilichin VA, et al. Novel organotin complexes with phenol and imidazole moieties for optimized antitumor properties. Journal of Organometallic Chemistry. 2022;959;122212. Doi: 10.1016/j.jorganchem.2021.122212

3. Додохова М.А., Сафроненко А.В., Котиева И.М., Сухорукова Н.В., Ганцгорн Е.В., Алхусейн-Кулягинова М.С., и др. Оценка фармакотерапевтического потенциала оловоорганических соединений in vivo. Биофармацевтический журнал. 2021;13(3):30-34. DOI: 10.30906/2073-8099-2021-13-3-30-34

4. Dodokhova MA, Safronenko AV, Kotieva IМ, Alkhuseyn-Kulyaginova MS, Shpakovsky DB, Milaev ER. Evaluation of the pharmacological activity of hybrid organotin compounds in a B16 melanoma model in the classical and metronomic administration modes. Research Results in Pharmacology. 2022;8(1):85–93. Doi: 10.3897/rrpharmacology.8.76363

5. Dodokhova M.A., Safronenko A.V., Kotieva I.M., Alkhuseyn-Kulyaginova M.S., Shpakovsky D.B., Milaeva E.R. Impact of organotin compounds on the growth of epidermoid Lewis carcinoma. Research Results in Pharmacology. 2021;7(4):81-88. Doi: 10.3897/rrpharmacology.7.71455

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3